Cipla Share Price (CIPLA)
Check the latest share price of Cipla, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 11:11AM, 03 Jul 2025
NSE
Cipla Stock Performance
Get live Cipla share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹1,498.8Day's Price Range₹1,508.852 Week's Low
52 Week's High
₹1,33552-Week Price Range₹1,702.05
| Returns % | |
| 1 Month Return | + 1.66 % |
| 3 Month Return | + 0.13 % |
| 1 Year Return | + 0.93 % |
| 3 Year Return | + 60.92 % |
| 5 Year Return | + 134.44 % |
| Market Stats | |
| Previous Close | ₹1,497.60 |
| Open | ₹1,503.60 |
| Volume | 1.53L |
| Upper Circuit | ₹1,647.30 |
| Lower Circuit | ₹1,347.90 |
Cipla Fundamentals & Key Indicators
Check Cipla market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,20,962.32 Cr
Return on Equity (ROE)
17.17
PE Ratio (TTM)
22.94
Return on capital employed (ROCE)
21.4
Industry PE ratio
55.73
Beta (LTM)
0.74
P/B Ratio
3.63
Dividend Yield
1.11
PEG Ratio
1.61
Quarterly Earnings Growth YOY
31.1
EPS (TTM)
65.52
Sector
Pharmaceuticals
Book Value
386.25
Technical Analysis
Bullish
View Technical Analysis
How to invest in Cipla?
Investing in Cipla is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Cipla or CIPLA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Cipla or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Cipla with just a few clicks!
Cipla Stock's Interest Amongst Investors
Cipla Valuation
Track how Cipla P/E has moved over time to understand its valuation trends.
Cipla in the last 5 years
Lowest (18.11x)
March 19, 2020
Today (22.94x)
July 2, 2025
Industry (55.73x)
July 2, 2025
Highest (42.80x)
January 23, 2018
Today’s Price to Earnings Ratio: 22.94x
Cipla Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Cipla.
based on 36 analysts
63.89%
Buy
19.44%
Hold
16.67%
Sell
63.89% of analysts recommend a 'BUY' rating for Cipla. Average target price of ₹1653.25
Source: S&P Global Market Intelligence
Cipla Share Price Target
Get share price movements and forecasts by analysts on Cipla.
Cipla price forecast by 36 analysts
Upside of10.39%
High
₹1875
Target
₹1653.25
Low
₹1280
Cipla target price ₹1653.25, a slight upside of 10.39% compared to current price of ₹1503.6. According to 36 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Cipla revenue growth forecast
Expected growth rate Q1, FY2027:15.61%
Forecast
Actual
Including amortisation and stock based compensations
Cipla EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Cipla Financial Results
Get the annual and quarterly financial summary of Cipla, including revenue, profit, loss and more.
Indices Featuring Cipla Stock
Check stock indices that include Cipla.
Cipla Earnings and Dividends
View detailed summary of the earnings and dividend history of Cipla.
Cipla Ltd Earnings Results
Cipla Ltd’s net profit jumped 30.12% since last year same period to ₹1,221.84Cr in the Q4 2024-2025. On a quarterly growth basis, Cipla Ltd has generated -22.2% fall in its net profits since last 3-months.
Read More about Earnings ResultsCipla Ltd Dividends May,2025
In the quarter ending March 2025, Cipla Ltd has declared dividend of ₹13 - translating a dividend yield of 1.07%.
Read More about Dividends
Cipla Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Cipla.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 29.13% | 0.00 | |
| Foreign Institutions | 26.22% | 0.00 | |
| Mutual Funds | 20.47% | 0.00 | |
| Retail Investors | 16.33% | 0.00 | |
| Others | 7.85% | 0.00 |
Cipla vs Peers
Compare market cap, revenue, PE, and other key metrics of Cipla with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 1,20,962.32 | 26.89% | 0.50 | 5,291 | 27,547 | |
| HOLD | 1,82,098.17 | 42.63% | 0.50 | 1,600 | 7,845 | |
| BUY | 1,13,353.82 | 35.94% | 0.67 | 1,656 | 10,727 | |
| BUY | 49,273.79 | -1.37% | 0.58 | 1,297 | 14,755 | |
| HOLD | 30,756.73 | 0.52% | 0.50 | 772 | 5,664 |
Cipla News & Key Events
Latest news and events in one place to help you make informed investing decisions in Cipla.
Cipla Expands Global Reach from China Factory - 02 Jul, 2025
Cipla is in discussions to enter at least two new overseas markets for products manufactured at its Jiangsu, China factory, aiming to alleviate production constraints in India. The factory, operational since 2024, produces inhalation products primarily for the U.S. market and has an annual capacity of 55 million units.Cipla Downgraded Amid Growth Concerns - 29 Jun, 2025
Emkay Global has downgraded Cipla Ltd to a 'Reduce' rating with a target price of Rs 1,500, citing challenges in domestic growth and uncertainties in US drug approvals.Cipla Reports Strong FY25 Performance and Dividends - 25 Jun, 2025
Cipla's FY25 annual report reveals a 7% revenue increase to Rs 27,548 crore, highest profit of Rs 5,273 crore, and a dividend of Rs 16 per share. The company launched 133 products and was granted 22 patents, focusing on growth through product launches and expansion.Cipla Announces Special and Final Dividends - 22 Jun, 2025
Cipla Ltd will declare a special dividend of ₹3 and a final dividend of ₹13 per share on June 27, 2025, signaling strong shareholder returns.Cipla Focuses on Sustainability Amid Regulatory Challenges - 18 Jun, 2025
Cipla Ltd is addressing regulatory constraints in pharma by enhancing sustainability efforts, including recycling 50% of water and achieving zero waste to landfill across all units in India.Cipla Stock Sees Significant Volume and Price Increase - 16 Jun, 2025
Cipla Ltd's stock experienced a notable rise of 2.09% to Rs 1,536.60, with trading volumes surging to 80,394 shares, indicating strong investor interest and positive market dynamics.Cipla Ltd Gains Amid New Campaign Launch - 11 Jun, 2025
Cipla Ltd's stock rose 0.42%, continuing a five-day upward trend. The company also launched a new Cipladine campaign featuring Neena Gupta, enhancing brand visibility.Cipla Achieves Water Positivity Certification - 05 Jun, 2025
Cipla has been certified as a water positive organization by Bureau Veritas for its India operations. The company reduced water withdrawal by 13.1% and 67% of its manufacturing units operate with Zero Liquid Discharge systems.
Insights on Cipla Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, CIPLA stock has moved up by 3.1%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 20.42% to 20.47% in Mar 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 29.13% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 50.0% return, outperforming this stock by 48.2%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.3% return, outperforming this stock by 72.4%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 1.57K Cr → 1.22K Cr (in ₹), with an average decrease of 22.2% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 7.29K Cr → 7.01K Cr (in ₹), with an average decrease of 3.8% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 16.41% to 16.33% in Mar 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 26.60% to 26.22% in Mar 2025 quarter
About Cipla
Cipla's operations include manufacturing, marketing, and distribution of pharmaceuticals, biotechnology, and consumer healthcare products. Its top products include respiratory, anti-infectives, cardiovascular, and oncology drugs. Popular brands include Asthalin, Cipcal, Cifran, and Erythromycin. Cipla also manufactures nutraceuticals, herbal products, and over-the-counter medicines.
Revenue: ₹6,597.72Cr as on March 2025 (Q4 FY25)
Net Profit: ₹1,225.02Cr as on March 2025 (Q4 FY25)
Listing date: 03 Nov, 1994
Chairperson Name: Y K Hamied
| Organisation | Cipla Ltd |
| Industry | Pharmaceuticals |
| CEO | Y K Hamied |
| E-voting on shares | Click here to vote |
Mutual Funds that own Cipla
Check out the Mutual Funds with significant holdings in Cipla.
FAQs
What is Cipla share price today?
Cipla share price today stands at ₹1503.6, Open: ₹1503.6, Previous Close: ₹1497.6, High: ₹1508.8, Low: ₹1498.8, 52 Week High: ₹1702.05, 52 Week Low: ₹1335.
What is today's traded volume of Cipla?
Today's traded volume of Cipla is 1.53L. Which means that 1.53L shares of Cipla were bought and sold on the stock market during today's trading session.
What is Cipla's market cap today?
Today's market capitalisation of Cipla is ₹1,20,962.32 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Cipla?
Cipla’s 52 week high is ₹1702.05 and 52 week low is ₹1335. The current share price of Cipla is ₹1503.6, which is -11.66% down from its 52 week high and 12.63% up from its 52 week low.